Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00145028 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Determination of Carboplatin's Optimal Plasmatic Exposure

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study Status, Study Design, Referencesv6
  2. Trial status: Recruiting to Completed
    • Primary completion date: Dec 2007
    • Study completion date changed from estimate of Dec 2008 to Feb 2009
    • Site details revised at 15 of 15 sites
    v5
  3. Re-verified, no change to tracked fieldsv4
  4. Study sites: 14 to 15
    • Study completion date: May 2007 to Dec 2008
    v3
  5. Study sites: 1 to 14v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To determine Carboplatin's optimal exposures(optimal AUCs)and parameters they depend on.
Trial Details
NCT Number NCT00145028
Lead Sponsor Institut Claudius Regaud
Conditions
(from sponsor)		 Neoplasms
Related terms Neoplasms
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov